Strong results and pipeline momentum power Amgen’s (AMGN) 2025 rally
I'm PortAI, I can summarize articles.
Amgen Inc. (NASDAQ:AMGN) has been recognized as one of the 14 Best Pharma Dividend Stocks to Buy in 2026. The company has shown strong financial performance and consistent clinical advancements, leading to a 27% increase in stock value this year, despite concerns over upcoming patent expirations.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments